MedPath

The Sensitivity and Specificity of Electrospun Containing Toluidine blue in the Detection of Oral Potentially Malignant Disorders

Phase 4
Conditions
Patients who are suspected of having oral potentially malignant disorders or non-healing ulcer more than 2 weeks without any identifiable cause requiring biopsy
Electrospun, Oral potentially malignant disorders, Toluidine blue, Sensitivity, Specificity
Registration Number
TCTR20220712007
Lead Sponsor
Royal College of Dental Surgeons
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
30
Inclusion Criteria

1.Male or female subjects age > 20 years old
2.Patients who are suspected of having oral potentially malignant disorders
3.Patients with non-healing ulcer more than 2 weeks without any identifiable cause
4.Patients who can be followed up
5.Patients who give their consent for the study

Exclusion Criteria

1.Patients with severe systemic diseases that interfere with or contraindication to the biopsy procedure
2.Patients with the presence of obvious invasive carcinomas
3.Patients who abandoned treatment
4.Patients who refuse the study
5.Patients who are allergic to toluidine blue, acetic acid, polyvinylpyrrolidone or local anesthetic agents

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Staining of oral potentially malignant disorders by the use of electrospun containing toluidine blue Time of treatment Visual examination
Secondary Outcome Measures
NameTimeMethod
Histopathological diagnosis Time of treatment Histopathological evaluation
© Copyright 2025. All Rights Reserved by MedPath